Bleichroeder’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.15M Sell
1,900,000
-100,000
-5% -$169K 0.31% 58
2026
Q2
$4.08M Hold
2,000,000
– – 0.73% 22
2026
Q1
$3.58M Hold
2,000,000
– – 0.62% 21
2025
Q4
$4.48M Hold
2,000,000
– – 0.79% 18
2025
Q3
$4.84M Hold
2,000,000
– – 0.94% 15
2025
Q2
$1.18M Hold
2,000,000
– – 0.29% 29
2025
Q1
$1.75M Hold
2,000,000
– – 0.47% 22
2024
Q4
$3.38M Buy
2,000,000
+155,000
+8% +$279K 0.85% 17
2024
Q3
$3.54M Sell
1,845,000
-767,500
-29% -$1.74M 0.95% 14
2024
Q2
$6.43M Buy
2,612,500
+612,500
+31% +$1.64M 1.91% 12
2024
Q1
$3.28M Hold
2,000,000
– – 0.82% 19
2023
Q4
$3.56M Hold
2,000,000
– – 0.79% 19
2023
Q3
$9.16M Hold
2,000,000
– – 2.26% 11
2023
Q2
$22.4M Hold
2,000,000
– – 4.54% 6
2023
Q1
$22.6M Hold
2,000,000
– – 4.83% 5
2022
Q4
$13.7M Hold
2,000,000
– – 2.98% 10
2022
Q3
$18M Buy
+2,000,000
New +$17.4M 3.76% 8

Other funds holding PROK

Bleichroeder's PROK Position: Q3 2026 in Review

Bleichroeder reduced its ProKidney (PROK) stake by 5% in Q3 2026, selling an estimated $169K and leaving 1,900,000 shares worth $3.15M. The position accounts for 0.31% of the portfolio, ranked #58.

Bleichroeder first reported a position in PROK in Q3 2022 and has held it in 17 quarters since. The position peaked at $22.6M in Q1 2023. 67 funds tracked by Wall St. Rank hold PROK as of Q3 2026.

  • Bleichroeder held 1,900,000 shares of ProKidney worth $3.15M as of Q3 2026.
  • Bleichroeder sold 100,000 ProKidney shares in Q3 2026, an estimated $169K.
  • ProKidney made up 0.31% of Bleichroeder's portfolio in Q3 2026, its #58 holding.
  • Bleichroeder first reported a position in ProKidney in Q3 2022 and has held it in 17 quarters since.
  • Bleichroeder's ProKidney position peaked at $22.6M in Q1 2023.
  • 67 funds tracked by Wall St. Rank held ProKidney as of Q3 2026.

Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.